Journal article
Short- and long-term efficacy of modafinil at improving quality of life in stroke survivors: A post hoc sub study of the modafinil in debilitating fatigue after stroke trial
TP Lillicrap, CR Levi, E Holliday, MW Parsons, A Bivard
Frontiers in Neurology | FRONTIERS MEDIA SA | Published : 2018
Abstract
Background: The phase-II modafinil in debilitating fatigue after stroke trial demonstrated that modafinil improves fatigue and quality of life in severely fatigued stroke survivors. For this study, we sought to examine the interaction between fatigue and quality of life after stroke and determine whether reducing fatigue resulted in improved quality of life. In addition, we followed up a subset of patients 12-months after the trial to assess the long-term outcomes of modafinil therapy. Methods: We used linear regression to analyze interaction between baseline fatigue, as measured by the multidimensional fatigue inventory (MFI), and quality of life, as measured by the stroke-specific quality ..
View full abstractGrants
Funding Acknowledgements
MIDAS was funded by a seed grant from The National Stroke Foundation of Australia.